Text Size

Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00229346
First received: September 28, 2005
Last updated: December 18, 2007
Last verified: December 2007
History of Changes
  Purpose

Assessing FM and psychiatric disorder in patients suffering from PMS or PMDD


Condition
Premenstrual Syndrome

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Sheba Medical Center:

Study Start Date: October 2004
Estimated Study Completion Date: January 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • PMDD
  • PMS
  • Referral to gynecologist clinic without symptoms of PMS or PMDD
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229346

Locations
Israel
Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229346     History of Changes
Other Study ID Numbers: SHEBA-04-3457-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: December 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Premenstrual Syndrome
Menstruation Disturbances
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013